ArticleEmerging microbes & infections2026
Pre-existing immunity to heartland virus protects rhesus macaques from challenge with severe fever with thrombocytopenia syndrome virus.
Article in Emerging microbes & infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heartland virus (HRTV) and Severe fever with thrombocytopenia syndrome virus (SFTSV) are closely related phenuiviruses that cause similar diseases in humans. However, animal disease models for both viruses are limited. Here, we first investigated whether human disease from SFTSV and HRTV could be recapitulated in rhesus macaques. In contrast to previous studies, we challenged rhesus macaques with a Japanese isolate of SFTSV. Although Japan reports higher human case fatality rates than many other regions, only mild disease was observed in infected rhesus macaques. Moreover, since animal models for HRTV are also limited, we challenged another group of rhesus macaques with HRTV. Although the animals seroconverted, clinical disease was not observed, suggesting rhesus macaques are unsuitable disease models for HRTV. Lastly, we subsequently tested whether immune responses raised against HRTV could cross-protect against SFTSV challenge and found that prior infection with HRTV limited SFTSV replication and signs of disease. Together, our data establishes a rhesus macaque model of SFTSV infection using a Japanese isolate of SFTSV and demonstrates that pre-existing immunity to HRTV can protect against infection with SFTSV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.